New treatment for advanced melanoma uses tumor to fight the disease
Summary
A new treatment called tumor-infiltrating lymphocyte (TIL) therapy has been approved by the FDA to help patients with advanced melanoma, a serious form of skin cancer. This therapy uses immune cells taken from the patient’s own tumor to fight the cancer.Key Facts
- The FDA has approved TIL therapy for advanced melanoma patients.
- TIL therapy works by using immune cells found inside a patient’s tumor.
- These immune cells are collected, grown in large numbers, and then given back to the patient.
- The therapy aims to strengthen the body’s natural ability to fight cancer.
- This treatment offers new hope for those with advanced melanoma, a type of skin cancer.
- The therapy is personalized because it uses the patient’s own tumor cells.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
